In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to EHRA Ivory (& above) Members, Fellows of the ESC and Young combined Members

Rapid improvement in left ventricular function after sinus rhythm restoration in patients with idiopathic cardiomyopathy and atrial fibrillation

Session Poster session 2

Speaker Bjoern Mueller-Edenborn

Congress : EHRA 2019

  • Topic : arrhythmias and device therapy
  • Sub-topic : Arrhythmias, General - Treatment
  • Session type : Poster Session
  • FP Number : P981

Authors : B Mueller-Edenborn (Bad Krozingen,DE), B Mueller-Edenborn (Bad Krozingen,DE), J Minners (Bad Krozingen,DE), J Allgeier (Bad Krozingen,DE), T Burkhard (Basel,CH), H Lehrmann (Bad Krozingen,DE), P Ruile (Bad Krozingen,DE), S Merz (Bad Krozingen,DE), M Allgeier (Bad Krozingen,DE), F-J Neumann (Bad Krozingen,DE), T Arentz (Bad Krozingen,DE), A Jadidi (Bad Krozingen,DE), N Jander (Bad Krozingen,DE)

15 views

Authors:
B Mueller-Edenborn1 , B Mueller-Edenborn1 , J Minners2 , J Allgeier1 , T Burkhard3 , H Lehrmann1 , P Ruile2 , S Merz2 , M Allgeier2 , F-J Neumann2 , T Arentz1 , A Jadidi1 , N Jander2 , 1University Heart Center Freiburg-Bad Krozingen, electrophysiology - Bad Krozingen - Germany , 2University Heart Center Freiburg-Bad Krozingen, cardiology - Bad Krozingen - Germany , 3University Hospital Basel, cardiology - Basel - Switzerland ,

Citation:

Background: Sinus rhythm restoration (SRR) in patients with atrial fibrillation and heart failure may improve systolic function and impact on consecutive clinical management such as ICD-implantation rate.

Purpose: To investigate time course and potential predictors of the response to SSR.

Methods: We prospectively studied 50 consecutive patients who presented in heart failure with reduced ejection fraction and concomitant AF. After exclusion of valvular and coronary artery disease patients underwent electrical cardioversion. Serial echocardiography, cardiac magnetic resonance imaging (cMRI), and 24h-ECGs were performed at baseline, and on days 3 and 40 following SRR.

Results: Baseline left ventricular ejection fraction (EF) of the study population (76% male, age 69±11y) was 30±7%. Sustained SRR (= three days) significantly improved EF (figure 1A; day 3: 43±7%, n=46; day 40: 53±9%, n=34; p<0.001) as quantified by echocardiography. Comparable results were obtained using cMRI (baseline: 29±8%; day 3: 42±9%).  Three patients showed no response to SRR (EF-improvement <15%). The percentage of patients meeting current criteria for ICD-implantation for primary prevention dropped from 76% (n=38) to 11% (n=3) on day 40 following SRR (figure 1B). No specific clinical or echocardiographic factor predicting improved EF after SRR could be identified.

Conclusions: The majority of patients presenting with non-ischemic, non-valvular heart failure with reduced ejection fraction and concomitant AF show a significant and rapid improvement in EF following SRR. An attempt at SRR and reassessment of the need for ICD implantation after 40 days may be warranted in all such patients.



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are